Performance Anxiety (Situational & Social Anxiety Disorder) Treatment
Covered by Aetna in California

Propranolol 10–40mg orally 30–60 minutes before a performance event for situational performance anxiety — first-line for public speaking, auditions, musical performances, presentations. Non-selective beta-blocker; reduces autonomic symptoms (palpitations, tremor, sweating) without sedation or cognitive impairment. Single-dose, as-needed use; no dependence or tolerance develops. Not appropriate for patients with asthma, significant bradycardia (HR <60), hypotension, or second/third-degree heart block.

Sertraline 25–50mg titrated to 50–200mg daily — FDA-approved first-line SSRI for generalized social anxiety disorder (social phobia); full effect takes 4–6 weeks; preferred for patients with chronic pervasive social anxiety beyond discrete performance situations. Paroxetine CR 12.5–37.5mg daily or immediate-release 10–60mg daily — FDA-approved for SAD; higher discontinuation-symptom risk than sertraline. Escitalopram 5–20mg daily — off-label for SAD with good evidence and favorable tolerability. Venlafaxine XR 37.5–225mg daily — FDA-approved SNRI for SAD, useful when comorbid depression is present. Buspirone 10–30mg twice daily — non-sedating anxiolytic for adjunctive use; onset 2–4 weeks.

Propranolol 10mg and 20mg generic tablets are Tier 1 covered under Aetna CA pharmacy benefit, typically $4–$10 for a supply. Sertraline, escitalopram, and paroxetine are all Tier 1 generics, typically $4–$20 monthly. Venlafaxine XR generic is Tier 1–2, typically $15–$30. All covered without prior authorization at standard doses. Under SB 855, Aetna CA cannot apply discriminatory quantitative limitations to mental health prescriptions compared to equivalent medical prescriptions.

Per AAFP and APA guidelines, benzodiazepines (alprazolam, clonazepam, lorazepam) are NOT first-line for anxiety disorders and carry risks of physical dependence, cognitive impairment, respiratory depression, and diversion. TDMD does not prescribe benzodiazepines via telehealth for new patients — consistent with California Medical Board telehealth prescribing standards and DEA regulations requiring an in-person patient-provider relationship prior to Schedule IV controlled substance prescribing via telemedicine without a DEA special registration. Patients already prescribed benzodiazepines by an established prescriber are encouraged to continue that relationship for controlled-substance management. Propranolol is NOT a controlled substance — it can be appropriately prescribed at first telehealth visit for situational performance anxiety. Cognitive behavioral therapy (CBT) remains the most durable treatment for social anxiety disorder and is encouraged as a complement to pharmacotherapy.

Yes. Propranolol prescribed for performance anxiety or social anxiety disorder is a covered pharmacy benefit under Aetna CA commercial plans. California SB 855 requires Aetna CA to cover medically necessary treatment for all mental health conditions — social anxiety disorder and performance anxiety are recognized mental health conditions. As a Tier 1 generic medication, propranolol typically costs $4–$10 for a supply after insurance. SB 855 also ensures Aetna CA cannot apply more restrictive quantity limits to anxiety medications than it applies to equivalent medical conditions. Note that propranolol for performance anxiety is sometimes billed under a cardiac or autonomic code — Dr. Bhavsar uses appropriate clinical coding to support coverage.

Benzodiazepines are Schedule IV controlled substances. DEA regulations require that a prescriber have a legitimate patient-provider relationship — which historically meant at least one in-person visit — before prescribing Schedule IV drugs via telemedicine for a new patient. While post-2025 DEA rules have created pathways for special registrations, TDMD's telehealth practice scope does not include initiating benzodiazepine therapy for new patients. Beyond the regulatory constraint, AAFP, APA, and NICE guidelines consistently recommend against benzodiazepines as first-line anxiety treatment due to their risks: physical dependence develops within weeks, withdrawal can be severe, cognitive impairment is documented, and they carry respiratory depression risk when combined with alcohol or opioids. Propranolol (non-controlled) is safer and highly effective for performance anxiety. SSRIs are the evidence-based first-line for chronic social anxiety disorder. If you have an established prescriber managing benzodiazepines, TDMD is happy to provide adjunctive care.

This requires careful clinical assessment and in most cases is contraindicated. Propranolol is a non-selective beta-blocker that blocks both cardiac beta-1 and bronchial beta-2 receptors. In patients with asthma or reactive airway disease, propranolol can precipitate bronchospasm — a potentially serious event. For patients with asthma, Dr. Bhavsar will not prescribe propranolol. The safer alternative is a selective beta-1 blocker (atenolol, metoprolol), which have substantially less effect on bronchial smooth muscle at standard doses — though they are not FDA-approved for performance anxiety, they are used off-label with a more favorable safety profile in mild asthma. For most asthmatic patients with performance anxiety, an SSRI or CBT referral is the preferred management pathway.

It matters significantly for treatment selection. Performance anxiety is situational — anxiety is triggered by specific performance contexts (public speaking, musical performance, presentations, tests) and does not occur in routine social interactions. Propranolol 10–40mg taken 30–60 minutes before the performance event is highly effective for discrete situational performance anxiety and is often the only pharmacotherapy needed. Social anxiety disorder (social phobia) is broader — anxiety is triggered by any situation involving social scrutiny or evaluation, including everyday conversations, eating in public, meeting new people, or being observed at work. SAD responds poorly to propranolol alone (which controls physical symptoms but not cognitive fear or behavioral avoidance) and requires an SSRI or SNRI (sertraline, paroxetine, venlafaxine XR — all FDA-approved for SAD) combined with cognitive behavioral therapy for sustained benefit. Dr. Bhavsar assesses the full anxiety pattern to ensure you receive the right treatment, not just symptom suppression.

Yes. Aetna commercial plans cover telehealth visits for Performance Anxiety (Situational & Social Anxiety Disorder) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your performance anxiety treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your performance anxiety treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.